| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,814 |
18,476 |
$1.63M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,182 |
3,883 |
$446K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,170 |
5,151 |
$414K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,941 |
15,512 |
$384K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,473 |
5,380 |
$379K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,067 |
3,058 |
$266K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,705 |
2,631 |
$127K |
| 92587 |
|
5,631 |
5,606 |
$125K |
| 99401 |
|
7,067 |
7,009 |
$101K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,040 |
1,038 |
$101K |
| 90461 |
|
5,137 |
5,004 |
$97K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,771 |
7,235 |
$77K |
| 90670 |
|
2,545 |
2,539 |
$46K |
| 99460 |
|
588 |
585 |
$38K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
505 |
502 |
$27K |
| 92552 |
|
792 |
791 |
$26K |
| 97802 |
|
6,803 |
6,761 |
$24K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
774 |
753 |
$21K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,251 |
3,224 |
$20K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
967 |
963 |
$16K |
| 81002 |
|
5,577 |
5,521 |
$13K |
| 85013 |
|
3,269 |
3,265 |
$12K |
| 85018 |
|
6,213 |
6,203 |
$11K |
| 0071A |
|
292 |
292 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
980 |
923 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
757 |
436 |
$10K |
| 99429 |
|
1,155 |
1,083 |
$10K |
| 0072A |
|
256 |
256 |
$10K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
414 |
412 |
$9K |
| H0001 |
Alcohol and/or drug assessment |
1,206 |
1,203 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
60 |
59 |
$7K |
| 92570 |
|
253 |
240 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,586 |
1,534 |
$5K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
106 |
104 |
$4K |
| 87428 |
|
96 |
93 |
$4K |
| 99173 |
|
2,851 |
2,835 |
$4K |
| 90648 |
|
1,373 |
1,372 |
$4K |
| 90671 |
|
409 |
409 |
$4K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,160 |
1,153 |
$4K |
| 86580 |
|
586 |
583 |
$3K |
| 0004A |
|
77 |
77 |
$3K |
| 90716 |
|
1,358 |
1,351 |
$3K |
| 90686 |
|
3,607 |
3,600 |
$3K |
| 90633 |
|
1,742 |
1,731 |
$3K |
| 90685 |
|
601 |
601 |
$2K |
| 90707 |
|
1,307 |
1,303 |
$2K |
| 0081A |
|
55 |
55 |
$2K |
| 90700 |
|
576 |
575 |
$2K |
| 99381 |
|
30 |
29 |
$2K |
| 0154A |
|
44 |
44 |
$2K |
| 90744 |
|
1,051 |
1,038 |
$2K |
| 0124A |
|
38 |
38 |
$2K |
| 90672 |
|
855 |
855 |
$1K |
| 99496 |
|
12 |
12 |
$1K |
| 99463 |
|
14 |
13 |
$1K |
| 0001A |
|
34 |
34 |
$1K |
| 94060 |
|
26 |
26 |
$1K |
| 90713 |
|
170 |
170 |
$1K |
| 0073A |
|
25 |
25 |
$1K |
| 90723 |
|
263 |
263 |
$750.02 |
| 90680 |
|
2,242 |
2,232 |
$714.02 |
| 0002A |
|
19 |
19 |
$649.57 |
| 99442 |
|
25 |
25 |
$636.68 |
| 99051 |
|
172 |
172 |
$603.21 |
| 0074A |
|
15 |
15 |
$567.44 |
| 99050 |
|
194 |
192 |
$545.15 |
| 0003A |
|
13 |
13 |
$537.66 |
| 90698 |
|
1,306 |
1,301 |
$410.55 |
| 90661 |
|
130 |
130 |
$331.65 |
| 90651 |
|
232 |
231 |
$306.26 |
| 94664 |
|
26 |
26 |
$275.13 |
| 99441 |
|
21 |
21 |
$238.14 |
| 96380 |
|
13 |
12 |
$199.28 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
60 |
59 |
$88.65 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15 |
15 |
$58.58 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
371 |
344 |
$40.33 |
| 99070 |
|
804 |
762 |
$26.60 |
| 99001 |
|
550 |
536 |
$17.04 |
| G9820 |
Documentation of a chlamydia screening test with proper follow-up |
295 |
291 |
$12.51 |
| 91307 |
|
566 |
514 |
$2.53 |
| 91308 |
|
102 |
100 |
$0.66 |
| 91300 |
|
213 |
206 |
$0.64 |
| 91315 |
|
37 |
37 |
$0.23 |
| 91312 |
|
33 |
33 |
$0.19 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
1,093 |
1,088 |
$0.09 |
| 3008F |
|
14,512 |
12,342 |
$0.04 |
| 3016F |
|
443 |
441 |
$0.00 |
| 3725F |
|
444 |
442 |
$0.00 |
| 99072 |
|
12,894 |
10,850 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
4,556 |
4,111 |
$0.00 |
| 90734 |
|
53 |
53 |
$0.00 |
| 87400 |
|
130 |
126 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| G9762 |
Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays |
30 |
30 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
7,479 |
6,820 |
$0.00 |
| 90696 |
|
196 |
196 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
421 |
386 |
$0.00 |
| 1036F |
|
442 |
440 |
$0.00 |
| 1000F |
|
443 |
441 |
$0.00 |
| 99000 |
|
28 |
28 |
$0.00 |
| 90647 |
|
54 |
54 |
$0.00 |
| 90619 |
|
49 |
49 |
$0.00 |
| 90660 |
|
12 |
12 |
$0.00 |